Connection

Michael von Bergwelt-Baildon to Risk Adjustment

Back to Details
This is a "connection" page, showing publications Michael von Bergwelt-Baildon has written about Risk Adjustment.
Michael von Bergwelt-Baildon
Connection Strength
0.040
Risk Adjustment
  1. Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial. Lancet Respir Med. 2021 08; 9(8):863-872.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.